Pfizer to acquire Medivation for $14 billion

Pharmaceutical giant Pfizer announced Monday that it has agreed to acquire Medivation in a $14 billion deal that would add a blockbuster drug to its cancer pipeline. Medivation, a San Francisco biopharmaceutical company, has been highly sought after in recent months. Its flagship product, Xtandi, is a prostate cancer treatment that generated $2.2 billion in sales over [...]

2016-09-08T21:02:18+00:00August 22nd, 2016|The Washington Post|

Verizon’s biggest problem in acquiring Yahoo — ‘They bought David Spade’

Just about the only excitement contained in Verizon’s announcement Monday that it plans to buy Yahoo’s core business for $4.83 billion could be found in the exclamation point lodged in Yahoo!’s trademarked name. “There was a collective yawn in the industry,” said Eric Goodness, lead Verizon analyst at Gartner. Yahoo made its name 20 years [...]

2016-08-22T16:40:25+00:00July 25th, 2016|The Washington Post|
Go to Top